Home > > Global Gene Therapy Market Report
The Gene Therapy market was valued at $7,193.4 Million in 2023, and is projected to reach $39,035.6 Million by 2030 growing at a CAGR of 27.52% from 2024 to 2030. Non-Viral Vectors segment is expected to be the highest contributor to this market, with $5,972.9 Million in 2023, and is anticipated to reach $26,751.9 Million by 2030, registering a CAGR of 24.03%. Viral Vectors segment is anticipated to reach $12,283.7 Million by 2030 with the highest CAGR of 38.64%. Viral Vectors and Non-Viral Vectors segments are expected to witness significant growth rates at a CAGR of 38.64% and 24.03% respectively, during the forecast period. Vector Non-Viral Vectors Viral Vectors Indication Neurological Diseases Cancer Hepatological Diseases Duchenne Muscular Dystrophy Other Indications Delivery Method In-Vivo Gene Theraoy Ex-Vivo Gene Theraoy BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China RoAPAC Middle East & Africa Latin America MEA